改良Rankin量表全局残疾结局的标准化命名:卒中治疗学术产业圆桌会议XI共识推荐
该共识针对改良Rankin量表(mRS)在急性卒中试验中结局命名混乱的问题,由卒中治疗学术产业圆桌会议采用迭代混合方法制定统一命名体系。推荐为7个mRS级别、12个二分 ranges及效用加权分析等23种数值结局提供健康状态术语和效价术语,以提升临床医生、患者及试验相关方对mRS结局含义的理解。
要点
- 推荐使用统一健康状态术语描述mRS各等级,如mRS 1为「有症状但无残疾」,mRS 5为「需持续护理」。
- 推荐使用效价术语区分结局好坏,如mRS 1为「极好」,mRS 5为「极差」。
- 标准化命名覆盖7个单级、12个正负二分范围及效用加权分析共23种mRS数值结局。
核心结论
- 采用统一、协调的mRS结局命名体系可增强临床医生、患者及试验相关方对mRS结局含义的理解。
研究设计与样本
- 由卒中治疗学术产业圆桌会议协作组采用迭代混合方法流程制定共识推荐。
主要发现
- 既往临床试验对mRS状态使用了多种且常相互矛盾的描述术语。
- 共识为23种不同mRS数值结局提供了健康状态术语和效价术语的具体指导。
关键数值与推荐
- 健康状态术语示例:mRS评分1为「有症状但无残疾」,mRS评分5为「需持续护理」。
- 效价术语示例:mRS评分1为「极好」,mRS评分5为「极差」。
- 命名覆盖全部7个mRS单级、12个正负二分mRS范围、正负滑动二分法及mRS效用加权分析。
临床怎么用
- 在急性卒中试验及临床报告中,对mRS结局统一采用本共识推荐的标准化健康状态术语和效价术语。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The modified Rankin Scale (mRS), a 7-level, clinician-reported, measure of global disability, is the most widely employed outcome scale in acute stroke trials. The scale's original development preceded the advent of modern clinimetrics, but substantial subsequent work has been performed to enable the mRS to meet robust contemporary scale standards. Prior research and consensus recommendations have focused on modernizing 2 aspects of the mRS: operationalized assignment of scale scores and statistical analysis of scale distributions. Another important characteristic of the mRS still requiring elaboration and specification to contemporary clinimetric standards is the Naming of scale outcomes. Recent clinical trials have used a bewildering variety, often mutually contradictory, of rubrics to describe scale states. Understanding of the meaning of mRS outcomes by clinicians, patients, and other clinical trial stakeholders would be greatly enhanced by use of a harmonized, uniform set of labels for the distinctive mRS outcomes that would be used consistently across trials. This statement advances such recommended rubrics, developed by the Stroke Therapy Academic Industry Roundtable collaboration using an iterative, mixed-methods process. Specific guidance is provided for health state terms (eg, Symptomatic but Nondisabled for mRS score 1; requires constant care for mRS score 5) and valence terms (eg, excellent for mRS score 1; very poor for mRS score 5) to employ for 23 distinct numeric mRS outcomes, including: all individual 7 mRS levels; all 12 positive and negative dichotomized mRS ranges, positive and negative sliding dichotomies; and utility-weighted analysis of the mRS.
引用
- Saver JL, Chaisinanunkul N, Campbell BCV, et al. Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI. Stroke. 2021. PMID: 34320814. doi:10.1161/STROKEAHA.121.034480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。